Kon, O M <br/><br/>
Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma.  [electronic resource] 

 -  Lancet (London, England)  Oct 1998 
 - 1109-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(97)12261-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Asthma--drug therapy<br/>CD4 Antigens--immunology<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Chronic Disease<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Lymphocyte Count--drug effects<br/>Male<br/>Middle Aged<br/>Respiratory Function Tests